Risk factors of temperature increase after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy

BackgroundCytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is the standard treatment for patients with peritoneal cancer (PC). Following CRS-HIPEC, patients may also face risks caused by whole body hyperthermia. This study analyzed the incidence of temperatur...

Full description

Bibliographic Details
Main Authors: Hui-xia Kang, Jun-ying Ma, Yan-yan Su, Shan Kang, Bao-jie Feng, Xiao-bei Feng, Xu-sha Wang, Yun-yun Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1120499/full